KalVista Pharmaceuticals, Inc. (KALV) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $338.09M | +1073.0% |
| 2024 | $28.82M | — |
| 2015 | $7.48M | -33.6% |
| 2014 | $11.27M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $338.09M | +1073.0% |
| 2024 | $28.82M | — |
| 2015 | $7.48M | -33.6% |
| 2014 | $11.27M | — |